{
    "eid": "2-s2.0-84941951492",
    "title": "Omics-based depression and inflammation research",
    "cover-date": "2015-01-01",
    "subject-areas": [
        {
            "$": "Psychiatry and Mental Health",
            "@code": "2738"
        }
    ],
    "keywords": [],
    "authors": [
        "Michael Maes"
    ],
    "citedby-count": 7,
    "ref-count": 5,
    "ref-list": [
        "Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression",
        "The neuroprogressive nature of major depressive disorder: Pathways to disease evolution and resistance, and therapeutic implications",
        "Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways",
        "In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression",
        "New drug targets in depression: Inflammatory, cell-mediate immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. and new drug candidates-Nrf2 activators and GSK-3 inhibitors"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Londrina",
            "affilname": "Universidade Estadual de Londrina",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Geelong",
            "affilname": "Deakin University",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Sao Paulo",
            "affilname": "Universidade Federal de S\u00e3o Paulo",
            "affiliation-country": "Brazil"
        }
    ],
    "funding": []
}